Categories Technology

IBM seeks $167 million in settlement from Groupon

IT giant IBM (IBM) and coupon site Groupon (GRPN) have been at war over patents since 2016. IBM had accused Groupon of infringing four technology patents that date back to early Internet innovations. The two companies are engaged in a 10-day federal trial in Delaware from July 16 onwards. On the first day of the trial, IBM demanded $167 million in settlement from the daily-deals website.

For 25 consecutive years, IBM was said to have the most extensive US patents. IBM claims that major tech companies like Facebook (FB) and Amazon (AMZN) have acquired the license to use IBM technology and pay between $20-50 million.

IBM initially approached Groupon regarding the patent violation in 2011 and since then has been trying to negotiate a license agreement with the Chicago-based company.  But when Groupon refused, IBM was forced to hit the company with a patent suit. Early this year, IBM also sued Expedia (EXPE) for infringing on its patents.

IBM looks to cryptocurrency

Stable coins are one of the latest trends in cryptocurrency. These are fixed on assets like gold, or other major currencies. Separately, the tech giant said it is teaming up with financial services provider Stronghold to test a new digital stable coin, with an aim to bring some security in the volatile crypto space. According to Fortune, the tech giant is currently testing the stable coin, or crypto dollar, on Stellar — the company’s Blockchain platform.

The growing interest in cryptocurrencies has been attracting a lot of attention. Recently asset manager BlackRock (BLK) hit the headlines after the company said it was evaluating different options of how it can take advantage of this emerging cryptocurrency market.

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top